Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | +1.28% | +1.13% | -5.65% |
Apr. 22 | Quest Diagnostics Launches New Test to Help Assess Alzheimer's Disease Risk | MT |
Apr. 11 | John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.65% | 14.45B | |
-11.82% | 87.77B | |
+14.64% | 82.08B | |
+13.31% | 30.03B | |
-10.66% | 17.08B | |
+3.80% | 12.37B | |
-31.75% | 11.89B | |
+4.40% | 12.17B | |
+26.50% | 11.62B | |
0.00% | 10.72B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Credit Suisse Raises Quest Diagnostics' PT to $146 From $143, Updates Estimates to Reflect Some Benefit From Tailwinds; Keeps Neutral Rating